Monday, February 17, 2025

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

FDA Requires RSV Vaccine Labels to Include Guillain-Barré Syndrome Risk

FDA Requires RSV Vaccine Labels to Include Guillain-Barré Syndrome Risk

On Jan. 7, 2025, the U.S. Food and Drug Administration (FDA) mandated and approved changes to the safety labeling for the Prescribing Information of two Respiratory Syncytial Virus (RSV) vaccines: Abrysvo (manufactured by Pfizer)1 and Arexvy (manufactured by GlaxoSmithKline Biologicals).2 This label change update is being required to inform both the public and health care […]

Search in Site

To search in site, type your keyword and hit enter

Search